Surgical treatment as an optimal solution for Dopamine Agonists resistant microprolactinoma: a case report

Authors

  • Stela Dodaj Author
  • Mirel Grada Author
  • Mirjeta Guni Author
  • Artemis Ibra Author
  • Vojsava Leka Author
  • Mentor Petrela Author

DOI:

https://doi.org/10.59928/jqhjxs76

Abstract

Background: Prolactinomas are the most common type of pituitary neuroendocrine tumors (PitNET). The treatment of PRL-secreting PitNET is medical, but in some conditions, surgery is needed. Case presentation : We report a case of a 34-years-old female with a history of a resistant PitNET with active galactorrhea, treated with oral contraceptives at the age of 23 due to elevated PRL levels and irregular menstrual cycles. Magnetic Resonance Image (MRI) revealed a solid sellar lesion, 8 mm, suggesting a micro PitNET. Treatment with Cabergoline resulted in regular menstrual cycles with first pregnancy at 31. Two years after, ga lactorrhea reappeared and PRL was 175 μg/L, without changes in tumor size. Despite high dose of Cabergoline, PRL remained high. Resistance to Dopamine Agonists (DAs) was concluded and surgery was suggested. Intervention : Endoscopic transsphenoidal surgery (ETSS) was performed resulting in gross total resection (GTR). Outcome : Immediately after surgery the PRL levels returned to normal range. Conclusion : It is crucial to identify in time DAs resistant prolactinomas and step up to surgery as the best treatment option, leading to GTR of microprolactinoma with satisfactory outcomes and normalization of PRL levels.

Downloads

Published

15-12-2024